Arcturus Therapeutics

ARCTNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$210.615 M

$7.41 +21.88%

Close of 7 Aug 2026

Revenue

$82.0M

#2584 by revenue

Earnings

-$65.8M

Loss-making

Shares outstanding

28,423,069

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#263Atrium TherapeuticsRNA$211.1M
#264Greenwich LifeSciencesGLSI$210.8M
#265Arcturus TherapeuticsARCT$210.6M
#266Satellos BioscienceMSLE$208.9M
#267NovaBridge BiosciencesNBP$201.9M

Where these numbers come from

Share counts and financials for Arcturus Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.